BIOSURFACTANTS AS SMART BIOCOMPATIBLE AGENTS IN PHARMACEUTICAL DRUG DELIVERY: ADVANCES IN FORMULATION, CHARACTERIZATION, AND THERAPEUTIC APPLICATIONS
DOI:
https://doi.org/10.22159/ajpcr.2026v19i2.56233Keywords:
Biosurfactants,, Drug delivery,, Glycolipids, Lipopeptides, Micelles, Nanoemulsions,, Solid lipid nanoparticles, Hydrogels, Gene therapy, Vaccine delivery,, Biocompatibility, Nanomedicine, Sustainable pharmaceuticalsAbstract
Biosurfactants are a diverse group of amphiphilic biomolecules derived from microbial sources, offering a promising alternative to synthetic surfactants for pharmaceutical applications. Their exceptional biocompatibility, biodegradability, and low toxicity make them attractive candidates for drug delivery systems. This review comprehensively explores the principles, types, and production of biosurfactants, with a specific focus on their integration into advanced pharmaceutical formulations. Various biosurfactant classes – including glycolipids, lipopeptides, and polymeric and particulate biosurfactants – are discussed in detail, highlighting their structural features and functional relevance. The production process, encompassing microbial fermentation, isolation, purification, and formulation strategies, such as micelles, nanoemulsions, liposomes, solid lipid nanoparticles, and hydrogels, is critically analyzed. Characterization techniques, including tensiometry, spectroscopy, electron microscopy, and biocompatibility assays, are also reviewed. Key pharmaceutical applications, such as solubility enhancement, controlled and targeted delivery, gene and protein transport, wound healing, cancer therapy, and vaccine delivery are addressed with current strategic advancements. The review concludes by outlining future perspectives, emphasizing synthetic biology, personalized nanomedicine, and artificial intelligence as tools to enhance biosurfactant utilization in drug delivery. Overall, biosurfactants represent a sustainable, multifunctional platform for next-generation therapeutic systems.
Downloads
References
1. Barbosa FG, Ribeaux DR, Rocha T, Costa RA, Guzmán RR, Marcelino P, et al. Biosurfactants: Sustainable and versatile molecules. J Braz Chem Soc. 2022;33(8):870-93. doi: 10.21577/0103-5053.20220074
2. Ceresa C, Fracchia L, Sansotera AC, De Rienzo MA, Banat IM. Harnessing the potential of biosurfactants for biomedical and pharmaceutical applications. Pharmaceutics. 2023;15(8):2156. doi: 10.3390/pharmaceutics15082156, PMID 37631370
3. Ceresa C, Fracchia L, Fedeli E, Porta C, Banat IM. Recent advances in biomedical, therapeutic and pharmaceutical applications of microbial surfactants. Pharmaceutics. 2021;13(4):466. doi: 10.3390/ pharmaceutics13040466, PMID 33808361
4. Banat IM, Carboué Q, Saucedo-Castañeda G, De Jesús Cázares- Marinero J. Biosurfactants: The green generation of speciality chemicals and potential production using solid-state fermentation (SSF) technology. Bioresour Technol. 2021;320(Pt A):124222. doi: 10.1016/j. biortech.2020.124222, PMID 33171346
5. Ohadi M, Shahravan A, Dehghannoudeh N, Eslaminejad T, Banat IM, Dehghannoudeh G. Potential use of microbial surfactant in microemulsion drug delivery system: A systematic review. Drug Des Devel Ther. 2020;14:541-50. doi: 10.2147/DDDT.S232325, PMID 32103896
6. Bjerk TR, Severino P, Jain S, Marques C, Silva AM, Pashirova T, et al. Biosurfactants: Properties and applications in drug delivery, biotechnology and ecotoxicology. Bioengineering (Basel). 2021;8(8):115. doi: 10.3390/bioengineering8080115, PMID 34436118
7. Hellweg T, Oberdisse J, Sottmann T. Recent advances in biosurfactant-based association colloids - formation of microemulsions. Front Soft Matter. 2023;3:1260211. doi: 10.3389/frsfm.2023.1260211
8. Wang X, An J, Cao T, Guo M, Han F. Application of biosurfactants in medical sciences. Molecules. 2024;29(11):2606. doi: 10.3390/ molecules29112606, PMID 38893481
9. Naughton PJ, Marchant R, Naughton V, Banat IM. Microbial biosurfactants: Current trends and applications in agricultural and biomedical industries. J Appl Microbiol. 2019;127(1):12-28. doi: 10.1111/jam.14243, PMID 30828919
10. Thakur V, Baghmare P, Verma A, Verma JS, Geed SR. Recent progress in microbial biosurfactants production strategies: Applications, technological bottlenecks, and future outlook. Bioresour Technol. 2024;408:131211. doi: 10.1016/j.biortech.2024.131211, PMID 39102966
11. Sarubbo LA, Silva MG, Durval IJ, Bezerra KG, Ribeiro BG, Silva IA, et al. Biosurfactants: Production, properties, applications, trends, and general perspectives. Biochem Eng J. 2022;181:108377. doi: 10.1016/j. bej.2022.108377
12. Maibaum L, Dinner AR, Chandler D. Micelle formation and the hydrophobic effect. J Phys Chem B. 2004;108(21):6778-81. doi: 10.1021/jp037487t
13. Shaimerdenova U, Kaiyrmanova G, Lewandowska W, Bartoszewicz M, Swiecicka I, Yernazarova A. Biosurfactant and biopolymer producing microorganisms from West Kazakhstan oilfield. Sci Rep. 2024;14(1):2294. doi: 10.1038/s41598-024-52906-7, PMID 38280982
14. Nayarisseri A, Singh P, Singh SK. Screening, isolation and characterization of biosurfactant producing Bacillus subtilis strain ANSKLAB03. Bioinformation. 2018;14(6):304-14. doi: 10.6026/97320630014304, PMID 30237676
15. El-Moslemany RM, El-Kamel A, Allam EA, Khalifa HM, Hussein A, Ashour AA. Tanshinone IIA loaded bioactive nanoemulsion for alleviation of lipopolysaccharide induced acute lung injury via inhibition of endothelial glycocalyx shedding. Biomed Pharmacotherapy. 2022;155:113666. doi: 10.1016/j.biopha.2022.113666
16. Hellweg T, Sottmann T, Oberdisse J. Recent advances in biosurfactant-based association colloids - self-assembly in water. Front Soft Matter. 2023;2:1081877. doi: 10.3389/frsfm.2022.1081877
17. Penfold J, Thompson L, Tucker I, Thomas RK, Li P, Dong Z, et al. Self-assembly and interfacial adsorption of biosurfactants: Recent insights from scattering techniques. Colloids Surf B Biointerfaces. 2023;222:113091. doi: 10.1016/j.colsurfb.2023.113091
18. Sharma J, Durai S, Srivastava P. Biosurfactants: Potential agents for controlling cellular communication, motility, and antagonism. Front Mol Biosci. 2021;8:727070. doi: 10.3389/fmolb.2021.727070, PMID 34708073
19. Akbari S, Rahimnejad M, Mokhtari-Hosseini ZB. Biotechnological production of biosurfactants for medical and pharmaceutical applications. Biotechnol Adv.;42:107579. doi: 10.1016/j.biotechadv.2020.107579
20. Datta M, Chattopadhyay I. Applications of microbial biosurfactants in human health and environmental sustainability: A narrative review. Discov Med. 2024;1(1):160. doi: 10.1007/s44337-024-00181-w
21. Płaza GA, Chojniak J, Banat IM. Biosurfactant mediated biosynthesis of selected metallic nanoparticles. Int J Mol Sci 2014;15(4):13720-37. doi: 10.3390/ijms150813720, PMID 25110864.
22. Romero Vega G, Gallo Stampino P. Bio-based surfactants and biosurfactants: An overview and main characteristics. Molecules. 2025;30(4):863. doi: 10.3390/molecules30040863, PMID 40005173
23. Mulligan CN. Recent advances in the environmental applications of biosurfactants. Curr Opin Colloid Interface Sci. 2009;14(5):372-8. doi: 10.1016/j.cocis.2009.06.005
24. Thakur P, Saini NK, Thakur VK, Gupta VK, Saini RV, Saini AK. Rhamnolipid the glycolipid biosurfactant: Emerging trends and promising strategies in the field of biotechnology and biomedicine. Microb Cell Fact. 2021;20(1):1. doi: 10.1186/s12934-020-01497-9, PMID 33397389
25. Lourenço M, Duarte N, Ribeiro IA. Exploring biosurfactants as antimicrobial approaches. Pharmaceuticals (Basel). 2024;17(9):1239. doi: 10.3390/ph17091239, PMID 39338401
26. Moussa TA, Mohamed MS, Samak N. Production and characterization of di-rhamnolipid produced by Pseudomonas aeruginosa TMN. Braz J Chem Eng. 2014;31(4):867-80. doi: 10.1590/0104- 6632.20140314s00002473
27. Carolin FC, Kamalesh T. Advances in stabilization of metallic nanoparticle with biosurfactants- a review on current trends. Heliyon. 2024;10:e29773. https://doi.org/10.1016/j.heliyon.2024.e29773
28. El-Housseiny GS, Aboshanab KM, Aboulwafa MM, Hassouna NA. Structural and physicochemical characterization of rhamnolipids produced by Pseudomonas aeruginosa P6. AMB Express. 2020;10(1):201. doi: 10.1186/s13568-020-01141-0, PMID 33146788
29. Eslami P, Hajfarajollah H, Bazsefidpar S. Recent advancements in the production of rhamnolipid biosurfactants by Pseudomonas aeruginosa. RSC Adv. 2020;10(56):34014-32. doi: 10.1039/D0RA04953K,PMID 35519061
30. Cho WY, Ng JF, Yap WH, Goh BH. Sophorolipids - bio-based antimicrobial formulating agents for applications in food and health. Molecules. 2022;27(17):5556. doi: 10.3390/molecules27175556, PMID 36080322
31. Elshafie AE, Joshi SJ, Al-Wahaibi YM, Al-Bemani AS, Al-Bahry SN, Al-Maqbali D, et al. Sophorolipids production by Candida bombicola ATCC 22214 and its potential application in microbial enhanced oil recovery. Front Microbiol. 2015;6:1324. doi: 10.3389/ fmicb.2015.01324, PMID 26635782.
32. Rodrigues LR, Banat IM. Biosurfactants: Promising molecules for therapeutic and pharmaceutical applications. Trends Biotechnol. 2020;38(10):1129-41. doi: 10.1016/j.tibtech.2020.02.015
33. Gupta R, Prabhune AA. Structural determination and chemical esterification of the sophorolipids produced by Candida bombicola grown on glucose and α-linolenic acid. Biotechnol Lett. 2012;34(4):701-7. doi: 10.1007/s10529-011-0818-y, PMID 22167634
34. Hu F, Cai W, Lin J, Wang W, Li S. Genetic engineering of the precursor supply pathway for the overproduction of the nC14-surfactin isoform with promising MEOR applications. Microb Cell Fact. 2021;20(1):96. doi: 10.1186/s12934-021-01585-4, PMID 33964901
35. Das B, Kumar B, Begum W, Bhattarai A, Mondal MH, Saha B. Comprehensive review on applications of surfactants in vaccine formulation, therapeutic and cosmetic pharmacy and prevention ofpulmonary failure due to COVID-19. Chem Afr. 2022;5(3):459-80. doi: 10.1007/s42250-022-00345-0
36. Das S, Rao KV. A comprehensive review of biosurfactant production and its uses in the pharmaceutical industry. Arch Microbiol. 2024;206(2):60. doi: 10.1007/s00203-023-03786-4, PMID 38197951
37. Ali N, Pang Z, Wang F, Xu B, El-Seedi HR. Lipopeptide biosurfactants from Bacillus spp.: Types, production, biological activities, and applications in food. J Food Qual. 2022;2022:1-19. doi: 10.1155/2022/3930112
38. Dunlap CA, Bowman MJ, Rooney AP. Iturinic lipopeptide diversity in the Bacillus subtilis species group - important antifungals for plant disease biocontrol applications. Front Microbiol. 2019;10:1794. doi: 10.3389/fmicb.2019.01794, PMID 31440222
39. Cooper DG, Zajic JE, Gerson DF. Production of surface-active lipids by Corynebacterium lepus. Appl Environ Microbiol. 1979;37(1):4-10. doi: 10.1128/AEM.37.1.4-10.1979, PMID 760639
40. Ahmadi-Ashtiani HR, Baldisserotto A, Cesa E, Manfredini S, Sedghi Zadeh H, Ghafori Gorab M, et al. Microbial biosurfactants as key multifunctional ingredients for sustainable cosmetics. Cosmetics. 2020;7(2):46. doi: 10.3390/cosmetics7020046
41. Sanjai C, Gaonkar S, Hakkimane S. Harnessing nature’s toolbox: Naturally derived bioactive compounds in nanotechnology enhanced formulations. ACS Omega. 2024;9:43302-43318. doi: 10.1021/acsomega.4c07756
42. Afolabi F, Mahmood SM, Yekeen N, Akbari S, Sharifigaliuk H. Polymeric surfactants for enhanced oil recovery: A review of recent progress. J Petrol Sci Eng. 2022;208:109358. doi: 10.1016/j.petrol.2021.109358
43. Alizadeh-Sani M, Hamishehkar H, Khezerlou A, Azizi-Lalabadi M, Azadi Y, Nattagh-Eshtivani E, et al. Bioemulsifiers derived from microorganisms: Applications in the drug and food industry. Adv Pharm Bull. 2018;8(2):191-9. doi: 10.15171/apb.2018.023, PMID 30023320
44. Desai JD, Banat IM. Microbial production of surfactants and their commercial potential. Microbiol Mol Biol Rev. 1997;61(1):47-64. doi: 10.1128/mmbr.61.1.47-64.1997, PMID 9106364
45. Yi G, Son J, Yoo J, Park C, Koo H. Emulsan-based nanoparticles for in vivo drug delivery to tumors. Biochem Biophys Res Commun. 2019;508(1):326-31. doi: 10.1016/j.bbrc.2018.11.106, PMID 30502086
46. Antonioli Júnior R, Poloni JF, Pinto ÉS, Dorn M. Interdisciplinary overview of lipopeptide and protein-containing biosurfactants. Genes (Basel). 2022;14(1):76. doi: 10.3390/genes14010076, PMID 36672817
47. Cirigliano MC, Carman GM. Purification and characterization of liposan, a bioemulsifier from Candida lipolytica. Appl Environ Microbiol. 1985;50(4):846-50. doi: 10.1128/AEM.50.4.846-850.1985, PMID 16346917
48. Santos DK, Rufino RD, Luna JM, Santos VA, Sarubbo LA. Biosurfactants: Multifunctional biomolecules of the 21st century. Int J Mol Sci. 2016;17(3):401. doi: 10.3390/ijms17030401, PMID 26999123
49. Thacharodi A, Lamont IL. Gene-gene interactions reduce aminoglycoside susceptibility of Pseudomonas aeruginosa through efflux pump-dependent and -independent mechanisms. Antibiotics (Basel). 2023;12(1):152. doi: 10.3390/antibiotics12010152,PMID 36671353
50. Ongena M, Jacques P. Bacillus lipopeptides: Versatile weapons for plant disease biocontrol. Trends Microbiol. 2008;16(3):115-25. doi: 10.1016/j.tim.2007.12.009, PMID 18289856
51. Bhattacharya A, Roy P. Recent trends in biosurfactant research: Applications in drug delivery and nanomedicine. Colloids Surf A Physicochem Eng Aspects. 2021;630:127561.
52. Goldman S, Shabtai Y, Rubinovitz C, Rosenberg E, Gutnick DL. Emulsan in Acinetobacter calcoaceticus RAG-1: Distribution of cell-free and cell-associated cross-reacting material. Appl Environ Microbiol. 1982;44(1):165-70. doi: 10.1128/AEM.44.1.165-170.1982, PMID 16346052
53. Bhatnagar A, Kaur H. Rhamnolipids in drug delivery: Emerging opportunities and design strategies. Pharm Nanotechnol. 2021;9(2):147-60.
54. Kathole A, Hatwar P. Nanotechnology-based drug delivery systems and herbal medicine. J Drug Deliv Ther. 2025;15:133-41.doi: 10.22270/ jddt.v15i3.7017
55. Chong H, Li Q. Microbial production of rhamnolipids: Opportunities, challenges and strategies. Microb Cell Fact. 2017;16(1):137. doi: 10.1186/s12934-017-0753-2, PMID 28779757
56. Zhou J, Xue R, Liu S, Xu N, Xin F, Zhang W, et al. High di-rhamnolipid production using Pseudomonas aeruginosa KT1115, separation of mono/di-rhamnolipids, and evaluation of their properties. Front Bioeng Biotechnol. 2019;7:245. doi: 10.3389/fbioe.2019.00245, PMID 31696112
57. Abdel-Mawgoud AM, Lépine F, Déziel E. Rhamnolipids: Diversity of structures, microbial origins and roles. Appl Microbiol Biotechnol. 2010;86(5):1323-36. doi: 10.1007/s00253-010-2498-2, PMID 20336292
58. Belisle JT, et al. Structure and function of mycobacterial lipids: Pathogenicity and immune response. Nat Rev Microbiol. 2009;7(7):543-55. doi: 10.1038/nrmicro2168
59. Sachin K, Karn SK. Microbial fabricated nanosystems: Applications in drug delivery and targeting. Front Chem. 2021;9:617353. doi: 10.3389/ fchem.2021.617353
60. Thakur S, Singh A, Sharma R, Aurora R, Jain SK. Biosurfactants as a novel additive in pharmaceutical formulations: Current trends and future implications. Curr Drug Metab. 2020;21(11):885-901. doi: 10.21 74/1389200221666201008143238, PMID 33032505
61. Satpute SK, Banpurkar AG, Dhakephalkar PK, Banat IM. Eco-friendly biosurfactants: New insights into their biomedical and biotechnological applications. Front Microbiol. 2020;11:437. doi: 10.3389/fmicb.2020.00437
62. Sultan F, Chattopadhyay I, Maji D, Phatake RS, Kumar K. Pharmaceutical applications of microbial biosurfactants: A comprehensive review. Int J Pharm. 2025;681:125887.
63. Madankar CS, Meshram A. Review on classification, physicochemical properties and applications of microbial surfactants. Tenside Surfactants Deterg. 2022;59(1):1-16. doi: 10.1515/tsd-2021-2353
64. Adetunji AI, Olaniran AO. Production and potential biotechnological applications of microbial surfactants: An overview. Saudi J Biol Sci. 2021;28(1):669-79. doi: 10.1016/j.sjbs.2020.10.058, PMID 33424354
65. Pardhi DS, Panchal RR, Raval VH, Joshi RG, Poczai P, Almalki WH, et al. Microbial surfactants: A journey from fundamentals to recent advances. Front Microbiol. 2022;13:982603. doi: 10.3389/ fmicb.2022.982603, PMID 35992692
66. Gayathiri E, Prakash P, Karmegam N, Varjani S, Awasthi M, Ravindran B. Biosurfactants: Potential and eco-friendly material for sustainable agriculture and environmental safety-a review. Agronomy. 2022;12(3):662. doi: 10.3390/agronomy12030662
67. Eras-Muñoz E, Farré A, Sánchez A, Font X, Gea T. Microbial biosurfactants: A review of recent environmental applications. Bioengineered. 2022;13(5):12365-91. doi: 10.1080/21655979.2022.2074621, PMID 35674010
68. Abu Yazid N, Barrena R, Komilis D, Sánchez A. Solid-state fermentation as a novel paradigm for organic waste valorization: A review. Sustainability. 2017;9(2):224. doi: 10.3390/su9020224
69. Sundaram T, Govindarajan RK, Vinayagam S, Krishnan V, Nagarajan S, Gnanasekaran GR, et al. Advancements in biosurfactant production using agro-industrial waste for industrial and environmental applications. Front Microbiol. 2024;15:1357302. doi: 10.3389/ fmicb.2024.1357302, PMID 38374917
70. Miao Y, To MH, Siddiqui MA, Wang H, Lodens S, Chopra SS, et al. Sustainable biosurfactant production from secondary feedstock - recent advances, process optimization and perspectives. Front Chem. 2024;12:1327113. doi: 10.3389/fchem.2024.1327113, PMID 38312346
71. Rane AN, Baikar VV, Ravi Kumar V, Deopurkar RL. Agro-industrial wastes for production of biosurfactant by Bacillus subtilis ANR 88 and its application in synthesis of silver and gold nanoparticles. Front Microbiol. 2017;8:492. doi: 10.3389/fmicb.2017.00492,PMID 28392783
72. Mohanty SS, Koul Y, Varjani S, Pandey A, Ngo HH, Chang JS, et al. A critical review on various feedstocks as sustainable substrates for biosurfactants production: A way towards cleaner production. Microb Cell Fact. 2021;20(1):120. doi: 10.1186/s12934-021-01613-3, PMID 34174898
73. Gurkok S, Ozdal M. Microbial biosurfactants: Properties, types, and production. J Pharm Biol Sci. 2021;2:2-7.
74. Albasri HM, Almohammadi AA, Alhhazmi A, Bukhari DA, Waznah MS, Mawad AM. Production and characterization of rhamnolipid biosurfactant from thermophilic Geobacillus stearothermophilus bacterium isolated from Uhud mountain. Front Microbiol. 2024;15:1358175. doi: 10.3389/ fmicb.2024.1358175, PMID 38873141
75. Kumar AM, Singh S, Kant C, Verma H, Kesawat MS, Bhatia S, et al. Microbial biosurfactant: A new frontier for sustainable agriculture and pharmaceutical industries. Antioxidants 2021;10(9):1472. doi: 10.3390/ antiox10091472
76. Qu D, Show PL, Miao X. Transcription factor ChbZIP1 from alkaliphilic microalgae Chlorella sp. BLD enhancing alkaline tolerance in transgenic Arabidopsis thaliana. Int J Mol Sci. 2016;22(5):2387. doi: 10.3390/ijms22052387
77. Pacwa-Płociniczak M, Płaza GA, Piotrowska-Seget Z, Cameotra SS. Environmental applications of biosurfactants: Recent advances. Int J Mol Sci. 2021;22(19):10444. doi: 10.3390/ijms221910444
78. Chen Y, Tang Y, Li Y, Rui Y, Zhang P. Enhancing the efficacy of active pharmaceutical ingredients in medicinal plants through nanoformulations: A promising field. Nanomaterials (Basel). 2024;14(19):1598. doi: 10.3390/nano14191598
79. Patel P, Garala K, Singh S, Prajapati B, Chittasupho C. Lipid-based nanoparticles in delivering bioactive compounds for improving therapeutic efficacy. Pharmaceuticals. 2024;17(3):329. doi: 10.3390/ph1703032980. Fernandes NA, Simões LA, Dias DR. Biosurfactants produced by yeasts: Fermentation, screening, recovery, purification, characterization, and applications. Fermentation. 2023;9(3):207. doi: 10.3390/ fermentation9030207
81. Marchut-Mikołajczyk O, Drożdżyński P, Polewczyk A, Smułek W, Antczak T. Biosurfactant from endophytic Bacillus pumilus 2A: Physicochemical characterization, production and optimization and potential for plant growth promotion. Microb Cell Fact. 2021;20(1):40. doi: 10.1186/s12934-021-01533-2, PMID 33557838
82. Zeb A, Rana I, Choi HI, Lee CH, Baek SW, Lim CW, et al. Potential and applications of nanocarriers for efficient delivery of biopharmaceuticals. Pharmaceutics. 2020;12(12):1184. doi: 10.3390/ pharmaceutics12121184
83. Almeida C, Pedro AQ, Tavares AP, Neves MC, Freire MG. Ionic-liquid-based approaches to improve biopharmaceuticals downstream processing and formulation. Front Bioeng Biotechnol. 2023;11:1037436. doi: 10.3389/fbioe.2023.1037436, PMID 36824351
84. Nascimento MF, Keković P, Ribeiro IA, Faria NT, Ferreira FC. Novel organic solvent nanofiltration approaches for microbial biosurfactants downstream processing. Membranes (Basel). 2023;13(1):81. doi: 10.3390/membranes13010081, PMID 36676888
85. Talla S, Wadher K, Umekar M, Lohiya R. Recent and relevant methodology in the advancement of solid dispersion. J Drug Deliv Ther. 2021;11(4):1-7.
86. Mahanty R.. Biosurfactant-based metallic nanoparticles in antimicrobial therapy: Recent advances and applications. Colloids Surf B Biointerfaces. 2024;235:112561. doi: 10.1016/j.colsurfb.2024.112561
87. Alharbi WS, Almughem FA, Almehmady AM, Jarallah SJ, Alsharif WK, Alzahrani N, et al. Phytosomes as an emerging nanotechnology platform for the topical delivery of bioactive phytochemicals. Pharmaceutics. 2021;13(9):1475. doi: 10.3390/pharmaceutics13091475
88. Hwang D, Ramsey JD, Kabanov AV. Polymeric micelles for the delivery of poorly soluble drugs: From nanoformulation to clinical approval. Adv Drug Deliv Rev. 2020;156:80-118. doi: 10.1016/j. addr.2020.09.009, PMID 32980449
89. Jacob S, Kather FS, Boddu SH, Shah J, Nair AB. Innovations in nanoemulsion technology: Enhancing drug delivery for oral, parenteral, and ophthalmic applications. Pharmaceutics. 2024;16(10):1333. doi: 10.3390/pharmaceutics16101333, PMID 39458662
90. Preeti S, Sambhakar S, Malik R, Bhatia S, Al Harrasi A, Rani C, et al. Nanoemulsion: An emerging novel technology for improving the bioavailability of drugs. Scientifica (Cairo). 2023;2023:6640103. doi: 10.1155/2023/6640103, PMID 37928749
91. Salim N, Ahmad N, Musa SH, Hashim R, Tadros TF, Basri M. Nanoemulsion as a topical delivery system of antipsoriatic drugs. RSC Adv. 2016;6(8):6234-50. doi: 10.1039/c5ra14946k
92. Aimonen K, Suhonen S, Hartikainen M, Lopes VR, Norppa H, Ferraz N, et al. Role of surface chemistry in the in vitro lung response to nanofibrillated cellulose. Nanomaterials (Basel). 2021;11(2):389. doi: 10.3390/nano11020389, PMID 33546402
93. Priya S, Desai VM, Singhvi G. Surface modification of lipid-based nanocarriers: A potential approach to enhance targeted drug delivery. ACS Omega. 2023;8(1):74-86. doi: 10.1021/acsomega.2c05976, PMID 36643539
94. Zhao J, Su J, Qin L, Zhang X, Mao Y, et al. Exploring the influence of inhaled liposome membrane fluidity on its interaction with pulmonary physiological barriers. Biomater Sci. 2020;8(23):6592-605. doi: 10.1039/D0BM01128C
95. Sharma VK, Sarwa KK, Mazumder B. Fluidity enhancement: A critical factor for performance of liposomal transdermal drug delivery system. J Liposome Res. 2014;24(2):83-9. doi: 10.3109/08982104.2013.847956, PMID 24160895
96. Elhissi A. Liposomes for pulmonary drug delivery: The role of formulation and inhalation device design. Curr Pharm Des. 2017;23(3):362-72. doi: 10.2174/1381612823666161116114732, PMID 27848886
97. Adu SA, Twigg MS, Naughton PJ, Marchant R, Banat IM. Characterisation of cytotoxicity and immunomodulatory effects of glycolipid biosurfactants on human keratinocytes. Appl Microbiol Biotechnol. 2023;107(1):137-52. doi: 10.1007/s00253-022-12302-5, PMID 36441210
98. Zouari R, Moalla-Rekik D, Sahnoun Z, Rebai T, Ellouze-Chaabouni S, Ghribi-Aydi D. Evaluation of dermal wound healing and in vitro antioxidant efficiency of Bacillus subtilis SPB1 biosurfactant. Biomed Pharmacother. 2016;84:878-91. doi: 10.1016/j.biopha.2016.09.084, PMID 27750203
99. Haddaji N, Bahloul B, Bahia W, Bechambi O, Mahdhi A. Development of nanotechnology-based drug delivery systems for controlling clinical multidrug-resistant Staphylococcus aureus and Escherichia coli associated with aerobic vaginitis. Pharmaceutics 2023;15(8):2133. doi: 10.3390/pharmaceutics15082133100. Adejumo S, Oli A, Okoye E, Nwakile C, Ojiako CM, Okezie U, et al. Biosurfactant production using mutant strains of Pseudomonas aeruginosa and Bacillus subtilis from agro-industrial wastes. Adv Pharm Bull. 2020;11(3):543-56. doi: 10.34172/APB.2021.063
101. Jalili A, Bagherifar R, Nokhodchi A, Conway B, Javadzadeh Y. Current advances in nanotechnology-mediated delivery of herbal and plant-derived medicines. Adv Pharm Bull. 2023;13(4):712-22. doi: 10.34172/apb.2023.087
102. Iskandar B, Liu TW, Mei HC, Kuo IC, Surboyo M, Lin HM, et al. Herbal nanoemulsions in cosmetic science: A comprehensive review of design, preparation, formulation, and characterization. J Food Drug Anal. 2024;32(3):428-58. doi: 10.38212/2224-6614.3526
103. Pardeshi SR, Deshmukh NS, Telange DR, Nangare SN, Sonar YY, Lakade SH, et al. Process development and quality attributes for the freeze-drying process in pharmaceuticals, biopharmaceuticals and nanomedicine delivery: A state-of-the-art review. Future J Pharm Sci. 2023;9(1):99. doi: 10.1186/s43094-023-00551-8
104. Luo WC, O’Reilly Beringhs A, Kim R, Zhang W, Patel SM, Bogner RH, et al. Impact of formulation on the quality and stability of freeze-dried nanoparticles. Eur J Pharm Biopharm. 2021;169:256-67. doi: 10.1016/j.ejpb.2021.10.014, PMID 34732383
105. Andreana I, Bincoletto V, Manzoli M, Rodà F, Giarraputo V, Milla P, et al. Freeze drying of polymer nanoparticles and liposomes exploiting different saccharide-based approaches. Materials (Basel). 2023;16(3):1212. doi: 10.3390/ma16031212, PMID 36770218
106. Yousfan A, Al Khatib AO, Omar AM, Salman S, Barrett G, Michael N, et al. Innovative microencapsulation of polymyxin B for enhanced antimicrobial efficacy via coated spray drying. Mol Pharm. 2025;22(1):113-30. doi: 10.1021/acs.molpharmaceut.4c00594, PMID 39378315
107. Ryu S, Park S, Lee HY, Lee H, Cho CW, Baek JS. Biodegradable nanoparticles-loaded PLGA microcapsule for the enhanced encapsulation efficiency and controlled release of hydrophilic drug. Int J Mol Sci. 2021;22(6):2792. doi: 10.3390/ijms22062792, PMID 33801871
108. Wang S, Ren Z, Li H, Xue Y, Zhang M, Li R, et al. Preparation and sustained-release of chitosan-alginate bilayer microcapsules containing aromatic compounds with different functional groups. Int J Biol Macromol. 2024;271(2):132663. doi: 10.1016/j. ijbiomac.2024.132663, PMID 38797291
109. Spindler LM, Feuerhake A, Ladel S, Günday C, Flamm J, Günday- Türeli N, et al. Nano-in-micro-particles consisting of PLGA nanoparticles embedded in chitosan microparticles via spray-drying enhances their uptake in the olfactory mucosa. Front Pharmacol. 2021;12:732954. doi: 10.3389/fphar.2021.732954, PMID 34539414
110. Bami MS, Khazaeli P, Lahiji SF, Dehghannoudeh G, Banat I, Ohadi M. Potential of biosurfactant as green pharmaceutical excipients for coating of microneedles: A mini review. AIMS Microbiol 2024;10:596-607. doi: 10.3934/microbiol.2024028
111. Abiola O, Olayinka B. Recent trends in biosurfactant applications for drug solubilization and targeted delivery. Front Bioeng Biotechnol. 2023;11:1186234. doi: 10.3389/fbioe.2023.1186234
112. Abouseoud M, Amrane A. Biosurfactants in pharmaceutical and therapeutic research: A comprehensive overview. Appl Microbiol Biotechnol. 2020;104(12):5117-34. doi: 10.1007/s00253-020-10542-3
113. Lee YC, Lee D, Park E, Jang SY, Cheon SY, Han S, et al. Rhamnolipid-coated W/O/W double emulsion nanoparticles for efficient delivery of doxorubicin/erlotinib and combination chemotherapy. J Nanobiotechnol. 2021;19:53. doi: 10.1186/s12951-021-00791-3
114. Najmi Z, Ebrahimipour G, Franzetti A, Banat IM. In situ downstream strategies for cost-effective bio/surfactant recovery. Biotechnol Appl Biochem. 2018;65(4):523-32. doi: 10.1002/bab.1641, PMID 29297935
115. Varjani SJ, Upasani VN. Critical review on biosurfactant analysis, purification and characterization using rhamnolipid as a model biosurfactant. Bioresour Technol. 2017;232:389-97. doi: 10.1016/j. biortech.2017.02.047, PMID 28238638
116. Gil CV, Rebocho AT, Esmail A, Sevrin C, Grandfils C, Torres CA, et al. Characterization of the thermostable biosurfactant produced by Burkholderia thailandensis DSM 13276. Polymers (Basel). 2022;14(10):2088. doi: 10.3390/polym14102088, PMID 35631971
117. Velioglu Z, Urek RO. Physicochemical and structural characterization of biosurfactant produced by Pleurotus djamor in solid-state fermentation. Biotechnol Bioprocess Eng. 2016;21(3):430-8. doi: 10.1007/s12257-016-0139-z
118. Udayasree PJ, Lakshmi VV. Biosurfactants - a review: Bridging the gap between microbial production and industrial application. Nanotechnol Percept. 2024;20(Suppl 16):3530-61. doi: 10.62441/ nano-ntp.vi.5547119. Ahmad Z, Ansari MJ. Microbial biosurfactants: Biocompatible nanomaterials for drug solubilization and targeted delivery. Adv Colloid Interface Sci. 2023;316:102891. doi: 10.1016/j. cis.2023.102891
120. Wojciechowski K, Borucka K, Mierzejewska J. Are all yeast biosurfactants really capable of lowering surface tension below 30 mN/m? Colloids Surf B Biointerfaces. 2023;230:113503. doi: 10.1016/j.colsurfb.2023.113503, PMID 37586111
121. Ahmed F, Rahman A. Marine microbial biosurfactants: A potential revolution in pharmaceutical nanotechnology. Mar Drugs. 2023;21(1):37. doi: 10.3390/md21010037
122. Baccile N, Seyrig C, Poirier A, Alonso-De Castro S, Roelants S, Abel S. Self-assembly, interfacial properties, interactions with macromolecules and molecular modelling and simulation of microbial bio-based amphiphiles (biosurfactants): A tutorial review. RSC Green Chem. 2021;2103:10829. doi: 10.48550/ arXiv.2103.10829
123. Ahmed N, Ali M. Eco-friendly biosurfactants in therapeutic nanotechnology: Opportunities and challenges. Environ Nanotechnol Monit Manag. 2021;15:100385. doi: 10.1016/j.enmm.2021.100385
124. Barbosa JA, Abdelsadig MS, Conway BR, Merchant HA. Using zeta potential to study the ionisation behaviour of polymers employed in modified-release dosage forms and estimating their pKa. Int J Pharm X. 2019;1:100024. doi: 10.1016/j.ijpx.2019.100024, PMID 31517289
125. Midekessa G, Godakumara K, Ord J, Viil J, Lättekivi F, Dissanayake K, et al. Zeta potential of extracellular vesicles: Toward understanding the attributes that determine colloidal stability. ACS Omega. 2020;5(27):16701-10. doi: 10.1021/acsomega.0c01582, PMID 32685837
126. Alsayegh SY, Disi ZA, Al-Ghouti MA, Zouari N. Evaluation by MALDI-TOF MS and PCA of the diversity of biosurfactants and their producing bacteria, as adaption to weathered oil components. Biotechnol Rep (Amst). 2021;31:e00660. doi: 10.1016/j.btre.2021. e00660, PMID 34557388
127. Sari IP, Basyiruddin MI, Hertadi R. Bioconversion of palm oil into biosurfactant by Halomonas meridiana BK-AB4 for the application of corrosion inhibitor. Indones J Chem. 2018;18(4):718-28. doi: 10.22146/ijc.27040
128. Darwesh OM, Mahmoud MS, Barakat KM, Abuellil A, Ahmad ME. Improving the bioremediation technology of contaminated wastewater using biosurfactants produced by novel Bacillus isolates. Heliyon. 2021;7(12):e08616. doi: 10.1016/j.heliyon.2021.e08616, PMID 34988315
129. Silva IA, Fortunato JG, Almeida FC, Alves RN, Cunha MC, Rufino RD, et al. Production and application of a new biosurfactant for solubilisation and mobilisation of residual oil from sand and seawater. Processes. 2024;12(8):1605. doi: 10.3390/pr12081605
130. Zompra AA, Chasapi SA, Twigg MS, Salek K, Anestopoulos I, Galanis A, et al. Marine biosurfactants: Recent advances and applications in marine environments. Front Mar Sci. 2022;9:1023287. doi: 10.3389/fmars.2022.1023287
131. Ahmed S, Khalid M. Microbial lipopeptides as emerging biosurfactants for advanced drug delivery applications. Colloids Surf B Biointerfaces. 2023;230:113591. doi: 10.1016/j. colsurfb.2023.113591
132. Purohit A, Das AJ, Ghosh D. Production and characterization of sophorolipid under yeast-mediated submerged fermentation utilizing agro-industrial waste. Curr Res Microb Sci. 2025;8:100334. doi: 10.1016/j.crmicr.2024.100334, PMID 39835269
133. Simões CR, Da Silva MW, De Souza RF, Hacha RR, Merma AG, Torem ML, et al. Biosurfactants: An overview of their properties, production, and application in mineral flotation. Resources. 2024;13(6):81. doi: 10.3390/resources13060081
134. Ndlovu T, Rautenbach M, Vosloo JA, Khan S, Khan W. Characterisation and antimicrobial activity of biosurfactant extracts produced by Bacillus amyloliquefaciens and Pseudomonas aeruginosa isolated from a wastewater treatment plant. AMB Express. 2017;7(1):108. doi: 10.1186/s13568-017-0363-8, PMID 28571306
135. Ciurko D, Chebbi A, Kruszelnicki M, Czapor-Irzabek H, Urbanek AK, Polowczyk I, et al. Production and characterization of lipopeptide biosurfactant from a new strain of Pseudomonas antarctica 28E using crude glycerol as a carbon source. RSC Adv. 2023;13(34):24129-39. doi: 10.1039/D3RA03408A, PMID 37577095
136. Twigg MS, Baccile N, Banat IM, Déziel E, Marchant R, Roelants S, et al. Microbial biosurfactant research: Time to improve the rigour in the reporting of synthesis, functional characterization and process development. Microb Biotechnol. 2021;14(1):147-70. doi: 10.1111/1751-7915.13704, PMID 33249753
137. Englerová K, Bedlovičová Z, Nemcová R, Király J, Maďar M, Hajdučková V, et al. Bacillus amyloliquefaciens-derived lipopeptide biosurfactants inhibit biofilm formation and expression of biofilm-related genes of Staphylococcus aureus. Antibiotics (Basel). 2021;10(10):1252. doi: 10.3390/antibiotics10101252, PMID 34680832
138. Moldes AB, Álvarez-Chaver P, Vecino X, Cruz JM. Purification of lipopeptide biosurfactant extracts obtained from a complex residual food stream using Tricine-SDS-PAGE electrophoresis. Front Bioeng Biotechnol. 2023;11:1199103. doi: 10.3389/fbioe.2023.1199103, PMID 37346790
139. Bezza FA, Tichapondwa SM, Chirwa EM. Synthesis of biosurfactant stabilized silver nanoparticles, characterization and their potential application for bactericidal purposes. J Hazard Mater. 2020;393:122319. doi: 10.1016/j.jhazmat.2020.122319, PMID 32120206
140. Smith JR, Olusanya TO, Lamprou DA. Characterization of drug delivery vehicles using atomic force microscopy: Current status. Expert Opin Drug Deliv. 2018;15(12):1211-21. doi: 10.1080/17425247.2018.1546693, PMID 30417712
141. Dzyhovskyi V, Romani A, Pula W, Bondi A, Ferrara F, Melloni E, et al. Characterization methods for nanoparticle-skin interactions: An overview. Life (Basel). 2024;14(5):599. doi: 10.3390/life14050599, PMID 38792620
142. Saadh MJ, Shallan MA, Hussein UA, Mohammed AQ, Al-Shuwaili SJ, Shikara M, et al. Advances in microscopy characterization techniques for lipid nanocarriers in drug delivery: A comprehensive review. Naunyn Schmiedebergs Arch Pharmacol. 2024;397(8):5463-81. doi: 10.1007/s00210-024-03033-7, PMID 38459989
143. Falsafi SR, Rostamabadi H, Assadpour E, Jafari SM. Morphology and microstructural analysis of bioactive-loaded micro/nanocarriers via microscopy techniques; CLSM/SEM/TEM/AFM. Adv Colloid Interface Sci. 2020;280:102166. doi: 10.1016/j.cis.2020.102166, PMID 32387755
144. Ali N, Ahmed M. Recent advances in glycolipid biosurfactants for biomedical nanotechnology. Front Mol Biosci. 2023;10:1116248. doi: 10.3389/fmolb.2023.1116248
145. Saranya P, Swarnalatha S, Sekaran G. Lipoprotein biosurfactant production from an extreme acidophile using fish oil and its immobilization in nanoporous activated carbon for the removal of Ca2+ and Cr3+ in aqueous solution. RSC Adv. 2014;4(64):34144-55. doi: 10.1039/C4RA03101F
146. Blanco I, Siracusa V. The use of thermal techniques in the characterization of bio-sourced polymers. Materials (Basel). 2021;14(7):1686. doi: 10.3390/ma14071686, PMID 33808127
147. Bastrzyk A, Fiedot-Toboła M, Maniak H, Polowczyk I, Płaza G. Surfactin as a green agent controlling the growth of porous calcite microstructures. Int J Mol Sci. 2020;21(15):5526. doi: 10.3390/ ijms21155526, PMID 32752269
148. Nikolova C, Gutierrez T. Biosurfactants and their applications in the oil and gas industry: Current state of knowledge and future perspectives. Front Bioeng Biotechnol. 2021;9:626639. doi: 10.3389/fbioe.2021.626639, PMID 33659240
149. Almeida C, Ramos A. Microbial biosurfactants for improving solubility and permeability in oral drug delivery. Pharm Dev Technol. 2020;25(8):1015-28. doi: 10.1080/10837450.2020.1762435
150. Subramaniam D, Sekaran S. In vitro biocompatibility assessment of a novel membrane containing magnesium-chitosan/carboxymethyl cellulose and alginate intended for bone tissue regeneration. Cureus. 2024;16(2):e54597. doi: 10.7759/cureus.54597, PMID 38523973
151. Akiyode O, George D, Getti G, Boateng J. Systematic comparison of the functional physico-chemical characteristics and biocidal activity of microbial derived biosurfactants on blood-derived and breast cancer cells. J Colloid Interface Sci. 2016;479:221-33. doi: 10.1016/j.jcis.2016.06.051, PMID 27390853
152. Voulgaridou GP, Mantso T, Anestopoulos I, Klavaris A, Katzastra C, Kiousi DE, et al. Toxicity profiling of biosurfactants produced by novel marine bacterial strains. Int J Mol Sci. 2021;22(5):2383. doi: 10.3390/ijms22052383, PMID 33673549
153. Al-Wasify RS, Hamed S. Recent progress in the therapeutic applications of microbial biosurfactants. Appl Microbiol Biotechnol. 2023;107(10):4521-35. doi: 10.1007/s00253-023-12466-1
154. Andrade C, Lima S. Rhamnolipids in transdermal drug delivery: Physicochemical and pharmacological perspectives. Drug Deliv Transl Res. 2023;13(5):1762-75. doi: 10.1007/s13346-023-01257-9
155. Araujo LV, Freitas F, Reis MA. Biosurfactants: Emerging biopolymersfor medical, pharmaceutical, and industrial uses. Int J Biol Macromol. 2022;217:181-99. doi: 10.1016/j.ijbiomac.2022.06.175
156. Arora D, Srivastava S. Emerging biomedical and pharmaceutical applications of microbial biosurfactants. Appl Microbiol Biotechnol. 2021;105(11):4409-24. doi: 10.1007/s00253-021-11292-4
157. Kaur G, Garg P, Kaur B, Chaudhary GR, Kumar S, Dilbaghi N, et al. Synthesis, thermal and surface activity of cationic single chain metal hybrid surfactants and their interaction with microbes and proteins. Soft Matter. 2019;15(11):2348-58. doi: 10.1039/C9SM00046A, PMID 30810157
158. Cheng C, Wu Z, McClements DJ, Zou L, Peng S, Zhou W, et al. Improvement on stability, loading capacity and sustained release of rhamnolipids modified curcumin liposomes. Colloids Surf B Biointerfaces. 2019;183:110460. doi: 10.1016/j. colsurfb.2019.110460, PMID 31473408
159. Mirchandani Y, Patravale VB, Singh B. Solid lipid nanoparticles for hydrophilic drugs. J Control Release. 2021;335:457-64. doi: 10.1016/j.jconrel.2021.06.003
160. Banat IM, De Rienzo MAD. Industrial and therapeutic applications of biosurfactants: An update on recent developments. Curr Opin Colloid Interface Sci. 2020;46:136-42. doi: 10.1016/j.cocis.2019.12.003
161. Ali MK, Moshikur RM, Wakabayashi R, Moniruzzaman M, Goto M. Biocompatible ionic liquid-mediated micelles for enhanced transdermal delivery of paclitaxel. ACS Appl Mater Interfaces. 2021;13(17):19745-55. doi: 10.1021/acsami.1c03111, PMID 33891816
162. Vasudevan S, Prabhune AA. Photophysical studies on curcumin-sophorolipid nanostructures: Applications in quorum quenching and imaging. R Soc Open Sci. 2018;5(2):170865. doi: 10.1098/ rsos.170865, PMID 29515826
163. Ohadi M, Forootanfar H, Dehghannoudeh G, Banat IM. The role of surfactants and biosurfactants in the wound healing process: A review. J Wound Care. 2023;32(Suppl 4A):S4-16. doi: 10.12968/ jowc.2023.32.sup4a.s4
164. Yi G, Son J, Yoo J, Park C, Koo H. Rhamnolipid nanoparticles for in vivo drug delivery and photodynamic therapy. Nanomedicine. 2019;19:12-21. doi: 10.1016/j.nano.2019.03.015, PMID 30981820
165. Wang Y, Lin M, Fan T, Zhou M, Yin R, Wang X. Advances of stimuli-responsive amphiphilic copolymer micelles in tumor therapy. Int J Nanomedicine. 2025;20:1-24. doi: 10.2147/IJN.S495387, PMID 39776491
166. Farhoudi L, Hosseinikhah SM, Kazemi-Beydokhti A, Arabi L, Alavizadeh SH, Moosavian SA, et al. pH-sensitive polymeric micelles enhance the co-delivery of doxorubicin and docetaxel: An emerging modality for treating breast cancer. Cancer Nano. 2024;15(1):37. doi: 10.1186/s12645-024-00275-1
167. Zhang XX, Lamanna CM, Kohman RE, McIntosh TJ, Han X, Grinstaff MW. Lipid-mediated DNA and siRNA transfection efficiency depends on peptide headgroup. Soft Matter. 2013;9(17):. doi: 10.1039/C3SM27633C, PMID 24391676
168. Hejabi F, Abbaszadeh MS, Taji S, O’Neill A, Farjadian F, Doroudian M. Nanocarriers: A novel strategy for the delivery of CRISPR/Cas systems. Front Chem. 2022;10:957572. doi: 10.3389/ fchem.2022.957572, PMID 36092658
169. Öktem M, Nguyen TH, Bosman ED, Fens MH, Caiazzo M, Mastrobattista E, et al. Lipopeptide-mediated delivery of CRISPR/Cas9 ribonucleoprotein complexes for gene editing and correction. J Control Release. 2025;383:113854. doi: 10.1016/j. jconrel.2025.113854, PMID 40389165
170. Ohadi M, Forootanfar H, Dehghannoudeh N, Banat IM, Dehghannoudeh G. The role of surfactants and biosurfactants in the wound healing process: A review. J Wound Care. 2023;32(Suppl 4A):S4-16. doi: 10.12968/jowc.2023.32.sup4a.s4
171. Banerjee A, Mukhopadhyay R. Biosurfactant-based nanocarriers in drug design and delivery: Advances and emerging trends. Pharmaceutics. 2023;15(10):2375. doi: 10.3390/ pharmaceutics15102375
172. Banerjee S, Mukherjee A. Biosurfactant-aided nanocarriers for improved drug delivery in cancer therapy. Front Oncol. 2023;13:1100124. doi: 10.3389/fonc.2023.1100124.
173. Bettencourt AF, Tomé C, Oliveira T, Martin V, Santos C, Gonçalves L, et al. Exploring the potential of chitosan-based particles as delivery-carriers for promising antimicrobial glycolipid biosurfactants. Carbohydr Polym. 2021;254:117433. doi: 10.1016/j. carbpol.2020.117433, PMID 33357906
174. Wadhawan A, Singh J, Sharma H, Handa S, Singh G, Kumar R, et al. Anticancer biosurfactant-loaded PLA-PEG nanoparticles induce apoptosis in human MDA-MB-231 breast cancer cells. ACS Omega. 2022;7(6):5231-41. doi: 10.1021/acsomega.1c06338, PMID 35187338
175. Sadri E, Khoee S, Moayeri S, Haji Ali B, Pirhajati Mahabadi V, Shirvalilou S, et al. Enhanced anti-tumor activity of transferrin/folate dual-targeting magnetic nanoparticles using chemo-thermo therapy on retinoblastoma cancer cells Y79. Sci Rep. 2023;13(1):22358. doi: 10.1038/s41598-023-49171-5, PMID 38102193
176. Huang W, Lang Y, Hakeem A, Lei Y, Gan L, Yang X. Surfactin-based nanoparticles loaded with doxorubicin to overcome multidrug resistance in cancers. Int J Nanomedicine. 2018;13:1723-36. doi: 10.2147/IJN.S157368, PMID 29606866
177. Wu YS, Ngai SC, Goh BH, Chan KG, Lee LH, Chuah LH. Anticancer activities of surfactin and potential application of nanotechnology assisted surfactin delivery. Front Pharmacol. 2017;8:761. doi: 10.3389/fphar.2017.00761, PMID 29123482
178. Jadhav A, Nagaraj K. Surfactant-enabled nanocarriers in breast cancer therapy: Targeted delivery and multidrug resistance reversal. Pharmaceutics. 2025;17(6):779. doi: 10.3390/ pharmaceutics17060779, PMID 40574091
179. Jazayeri SD, Lim HX, Shameli K, Yeap SK, Poh CL. Nano and microparticles as potential oral vaccine carriers and adjuvants against infectious diseases. Front Pharmacol. 2021;12:682286. doi: 10.3389/ fphar.2021.682286, PMID 34149426
180. Zhang Z, Yang Y, Huang L, Yuan L, Huang S, Zeng Z, et al. Nanotechnology-driven advances in intranasal vaccine delivery systems against infectious diseases. Front Immunol. 2025;16:1573037. doi: 10.3389/fimmu.2025.1573037, PMID 40416956
181. Nishino M, Mizuno D, Kimoto T, Shinahara W, Fukuta A, Takei T, et al. Influenza vaccine with Surfacten, a modified pulmonary surfactant, induces systemic and mucosal immune responses without side effects in Minipigs. Vaccine. 2009;27(41):5620-7. doi: 10.1016/j.vaccine.2009.07.024, PMID 19647064
182. Calzas C, Chevalier C. Innovative mucosal vaccine formulations against influenza A virus infections. Front Immunol. 2019;10:1605. doi: 10.3389/fimmu.2019.01605, PMID 31379823
183. Li Z, Luo B, Chen Y, Wang L, Liu Y, Jia J, et al. Nanomaterial-based encapsulation of biochemicals for targeted sepsis therapy. Mater Today Bio. 2025;33:100635.
184. Poomalai P, Krishnan J, Ravichandran A, Sureshkumar R. Biosurfactants: Sustainable alternative to synthetic surfactants and their applications. Int J Appl Pharm. 2024;16(2):34-43. doi: 10.22159/ijap.2024v16i2.50061
185. Saxena T, Reddy PM, Sruthi Y, Nijhawan M. Self-microemulsifying drug delivery system: Special emphasis on various surfactants used in SMEDDS. Int J Pharm Sci Res. 2025;16(2):336-44. doi: 10.13040/IJPSR.0975-8232.16(2).336-44
Published
How to Cite
Issue
Section
Copyright (c) 2025 Sharmila V, Kasimani R, Esath Natheer S, Karuppasamy Chellapandi
This work is licensed under a Creative Commons Attribution 4.0 International License.
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.